Background: Hepatocellular carcinoma (HCC) is the sixth most commonly-diagnosed cancer globally, and the second-leading cause of cancer deaths annually. To better understand the patient journey we conducted the first global survey of patients with HCC in 13 countries.The survey was live from November 2016 to April 2017 and gathered data from 256 respondents